The JAK/STAT pathway appears to be active in many solid tumors, including ovarian cancer, breast cancer, prostate cancer, lung cancer, gastric cancer as well as in hematologic malignancies [13], [14], [15], [16], [17], [18]. This evidence concerns the gene SOAT1 and gastric cancer.